Emergency granulopoiesis

Nature Reviews Immunology

Volumn 14, Issue 5, 2014, Pages 302-314

  Manz, Markus G ^a   Boettcher, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

BONE MARROW; CELL PROLIFERATION; EMERGENCY GRANULOPOIESIS; FEEDBACK SYSTEM; GRANULOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; MYELOID PROGENITOR CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE GRANULOPOIESIS; REVIEW; SIGNAL TRANSDUCTION; STEADY STATE; STEM CELL; SURVIVAL;

ANIMALS; BONE MARROW; CELL GROWTH PROCESSES; HEMATOPOIESIS; HUMANS; NEUTROPHILS;

EID: 84899640120     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3660     Document Type: Review

References (130)

1. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759-806 (2003).
2. Tak, T., Tesselaar, K., Pillay, J., Borghans, J. A. & Koenderman, L. What's your age again? Determination of human neutrophil half-lives revisited. J. Leukoc. Biol. 94, 595-601 (2013).
3. Dancey, J. T., Deubelbeiss, K. A., Harker, L. A. & Finch, C. A. Neutrophil kinetics in man. J. Clin. Invest. 58, 705-715 (1976).
4. Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nature Rev. Immunol. 13, 159-175 (2013).
5. Elks, P. M. et al. Activation of hypoxia-inducible factor?1α (Hif?1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 118, 712-722 (2011).
6. Mathias, J. R. et al. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 80, 1281-1288 (2006).
7. Woodfin, A. et al. The junctional adhesion molecule JAM?C regulates polarized transendothelial migration of neutrophils in vivo. Nature Immunol. 12, 761-769 (2011).
8. Bonilla, M. A. et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N. Engl. J. Med. 320, 1574-1580 (1989).
9. Bennett, C. L., Djulbegovic, B., Norris, L. B. & Armitage, J. O. Colony-stimulating factors for febrile neutropenia during cancer therapy. N. Engl. J. Med. 368, 1131-1139 (2013).
10. Croker, B. A. et al. SOCS3 is a critical physiological negative regulator of G?CSF signaling and emergency granulopoiesis. Immunity 20, 153-165 (2004).
11. Watari, K. et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73, 117-122 (1989).
12. Kawakami, M. et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76, 1962-1964 (1990).
13. Cebon, J., Layton, J. E., Maher, D. & Morstyn, G. Endogenous haemopoietic growth factors in neutropenia and infection. Br. J. Haematol. 86, 265-274 (1994).
14. Cheers, C. et al. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 56, 247-251 (1988).
15. Selig, C. & Nothdurft, W. Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect. Immun. 63, 104-109 (1995).
16. Presneill, J. J. et al. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality. Crit. Care Med. 28, 2344-2354 (2000).
17. Waring, P. M. et al. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. Clin. Exp. Immunol. 102, 501-506 (1995).
18. Tanaka, H., Ishikawa, K., Nishino, M., Shimazu, T. & Yoshioka, T. Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J. Trauma 40, 718-725 (1996).
19. Hamilton, J. A. Colony-stimulating factors in inflammation and autoimmunity. Nature Rev. Immunol. 8, 533-544 (2008).
20. Kaushansky, K. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354, 2034-2045 (2006).
21. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. & de Vries, J. E. Interleukin 10(IL?10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL?10 produced by monocytes. J. Exp. Med. 174, 1209-1220 (1991).
22. He, R. L. et al. Serum amyloid A induces G?CSF expression and neutrophilia via Toll-like receptor 2. Blood 113, 429-437 (2009).
23. Vellenga, E., Rambaldi, A., Ernst, T. J., Ostapovicz, D. & Griffin, J. D. Independent regulation of M?CSF and G?CSF gene expression in human monocytes. Blood 71, 1529-1532 (1988).
24. Nishizawa, M. & Nagata, S. Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol. Cell. Biol. 10, 2002-2011 (1990).
25. Schilling, J. D., Martin, S. M., Hung, C. S., Lorenz, R. G. & Hultgren, S. J. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 100, 4203-4208 (2003).
26. Hammad, H. et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nature Med. 15, 410-416 (2009).
27. Andonegui, G. et al. Endothelium-derived Toll-like receptor?4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J. Clin. Invest. 111, 1011-1020 (2003).
28. Andonegui, G. et al. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J. Clin. Invest. 119, 1921-1930 (2009).
29. Hwa Cho, H., Bae, Y. C. & Jung, J. S. Role of Toll-like receptors on human adipose-derived stromal cells. Stem Cells 24, 2744-2752 (2006).
30. Liotta, F. et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T?cell modulatory activity by impairing Notch signaling. Stem Cells 26, 279-289 (2008).
31. Tomchuck, S. L. et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99-107 (2008).
32. Pevsner-Fischer, M. et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 1422-1432 (2007).
33. Shi, C. et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34, 590-601 (2011).
34. Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792-804 (2013).
35. Boettcher, S. et al. Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4?expressing nonhematopoietic cells. J. Immunol. 188, 5824-5828 (2012).
36. Schmid, M. A., Takizawa, H., Baumjohann, D. R., Saito, Y. & Manz, M. G. Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 118, 4829-4840 (2011).
37. Nagai, Y. et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801-812 (2006).
38. Chicha, L., Jarrossay, D. & Manz, M. G. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J. Exp. Med. 200, 1519-1524 (2004).
39. De Luca, K. et al. The TLR1/2 agonist PAM3CSK4 instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 23, 2063-2074 (2009).
40. Sioud, M. & Floisand, Y. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1?type response. Eur. J. Immunol. 37, 2834-2846 (2007).
41. Sioud, M., Floisand, Y., Forfang, L. & Lund- Johansen, F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J. Mol. Biol. 364, 945-954 (2006).
42. Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L. & Weissman, I. L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933-1936 (2001).
43. Massberg, S. et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131, 994-1008 (2007).
44. Onai, N. et al. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nature Immunol. 8, 1207-1216 (2007).
45. Zhao, J. L. et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell http://dx.doi. org/10.1016/j.stem.2014.01.007 (2014).
46. Schurch, C. M., Riether, C. & Ochsenbein, A. F. Cytotoxic CD8 T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell http://dx.doi.org/10.1016/j. stem.2014.01.002 (2014).
47. Takizawa, H., Regoes, R. R., Boddupalli, C. S., Bonhoeffer, S. & Manz, M. G. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 208, 273-284 (2011).
48. Zhang, P. et al. The lineagec?Kit+Sca?1+ cell response to Escherichia coli bacteremia in Balb/c mice. Stem Cells 26, 1778-1786 (2008).
49. Rodriguez, S. et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 114, 4064-4076 (2009).
50. Chen, C., Liu, Y. & Zheng, P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. J. Clin. Invest. 120, 4091-4101 (2010).
51. Esplin, B. L. et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J. Immunol. 186, 5367-5375 (2011).
52. Ichii, M. et al. Functional diversity of stem and progenitor cells with B?lymphopoietic potential. Immunol. Rev. 237, 10-21 (2010).
53. Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746 (1994).
54. Liu, F., Wu, H. Y., Wesselschmidt, R., Kornaga, T. & Link, D. C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501 (1996).
55. Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R. & Cheers, C. Essential roles for granulocyte-macrophage colony-stimulating factor (GM?CSF) and G?CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863-869 (1998).
56. Basu, S. et al. "Emergency" granulopoiesis in G?CSF-deficient mice in response to Candida albicans infection. Blood 95, 3725-3733 (2000).
57. Gasson, J. C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77, 1131-1145 (1991).
58. Lang, R. A. et al. Transgenic mice expressing a hemopoietic growth factor gene (GM?CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51, 675-686 (1987).
59. Metcalf, D. et al. Hemopoietic responses in mice injected with purified recombinant murine GM?CSF. Exp. Hematol. 15, 1-9 (1987).
60. Stanley, E. et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. USA 91, 5592-5596 (1994).
61. Seymour, J. F. et al. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90, 3037-3049 (1997).
62. Kingston, D. et al. The concerted action of GM?CSF and Flt3?ligand on in vivo dendritic cell homeostasis. Blood 114, 835-843 (2009).
63. Zhan, Y. & Cheers, C. Haemopoiesis in mice genetically lacking granulocyte-macrophage colony stimulating factor during chronic infection with Mycobacterium avium. Immunol. Cell Biol. 78, 118-123 (2000).
64. Hibbs, M. L. et al. Mice lacking three myeloid colony-stimulating factors (G?CSF, GM?CSF, and M?CSF) still produce macrophages and granulocytes and mount an inflammatory response in a sterile model of peritonitis. J. Immunol. 178, 6435-6443 (2007).
65. Romani, L. et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6?deficient mice infected with Candida albicans. J. Exp. Med. 183, 1345-1355 (1996).
66. Walker, F. et al. IL6/sIL6R complex contributes to emergency granulopoietic responses in G.CSF- and GM.CSF-deficient mice. Blood 111, 3978-3985 (2008).
67. King, K. Y. & Goodell, M. A. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nature Rev. Immunol. 11, 685-692 (2011).
68. Mercier, F. E., Ragu, C. & Scadden, D. T. The bone marrow at the crossroads of blood and immunity. Nature Rev. Immunol. 12, 49-60 (2012).
69. Takizawa, H., Boettcher, S. & Manz, M. G. Demandadapted regulation of early hematopoiesis in infection and inflammation. Blood 119, 2991-3002 (2012).
70. McKinstry, W. J. et al. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89, 65-71 (1997).
71. Adolfsson, J. et al. Identification of Flt3+ lymphomyeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
72. Panopoulos, A. D. et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108, 3682-3690 (2006).
73. Zhang, H. et al. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116, 2462-2471 (2010).
74. Hirai, H. et al. C/EBPfÀ is required for eemergencyf granulopoiesis. Nature Immunol. 7, 732-739 (2006).
75. Satake, S. et al. C/EBPfÀ is involved in the amplification of early granulocyte precursors during candidemiainduced gemergencyh granulopoiesis. J. Immunol. 189, 4546-4555 (2012).
76. Metcalf, D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood 92, 345-352 (1998).
77. Iwasaki-Arai, J., Iwasaki, H., Miyamoto, T., Watanabe, S. & Akashi, K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J. Exp. Med. 197, 1311-1322 (2003).
78. Kondo, M. et al. Cell-fate conversion of lymphoidcommitted progenitors by instructive actions of cytokines. Nature 407, 383-386 (2000).
79. Onai, N., Obata-Onai, A., Tussiwand, R., Lanzavecchia, A. & Manz, M. G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J. Exp. Med. 203, 227-238 (2006).
80. King, A. G., Kondo, M., Scherer, D. C. & Weissman, I. L. Lineage infidelity in myeloid cells with TCR gene rearrangement: A latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc. Natl Acad. Sci. USA 99, 4508-4513 (2002).
81. Rieger, M. A., Hoppe, P. S., Smejkal, B. M., Eitelhuber, A. C. & Schroeder, T. Hematopoietic cytokines can instruct lineage choice. Science 325, 217-218 (2009).
82. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005).
83. Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C. & Goodell, M. A. Quiescent haematopoietic stem cells are activated by IFN-fÁ in response to chronic infection. Nature 465, 793-797 (2010).
84. Essers, M. A. et al. IFNf activates dormant haematopoietic stem cells in vivo. Nature 458, 904-908 (2009).
85. Sato, T. et al. Interferon regulatory factor.2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nature Med. 15, 696-700 (2009).
86. de Bruin, A. M., Demirel, O., Hooibrink, B., Brandts, C. H. & Nolte, M. A. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood 121, 3578-3585 (2013).
87. Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129 (2008).
88. Saito, Y. et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nature Biotech. 28, 275-280 (2010).
89. Mossadegh-Keller, N. et al. M.CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497, 239-243 (2013).
90. Rosenbauer, F. & Tenen, D. G. Transcription factors in myeloid development: balancing differentiation with transformation. Nature Rev. Immunol. 7, 105-117 (2007).
91. Zhang, D. E. et al. Absence of granulocyte colonystimulating factor signaling and neutrophil development in CCAAT enhancer binding protein f-deficient mice. Proc. Natl Acad. Sci. USA 94, 569-574 (1997).
92. Zhang, P. et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPf. Immunity 21, 853-863 (2004).
93. Zhang, P. et al. Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein-f (C/EBPf) is critical for granulopoiesis. J. Exp. Med. 188, 1173-1184 (1998).
94. Collins, S. J., Ulmer, J., Purton, L. E. & Darlington, G. Multipotent hematopoietic cell lines derived from C/EBPalpha(./.) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocytecolony- stimulating factor, and retinoic acid-induced granulocytic differentiation. Blood 98, 2382-2388 (2001).
95. Zhang, P. et al. Induction of granulocytic differentiation by 2 pathways. Blood 99, 4406-4412 (2002).
96. Akagi, T. et al. Impaired response to GM.CSF and G.CSF, and enhanced apoptosis in C/EBPfÀ-deficient hematopoietic cells. Blood 111, 2999-3004 (2008).
97. Wang, H. et al. C/EBPf arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol. Cell 8, 817-828 (2001).
98. Johansen, L. M. et al. c.Myc is a critical target for c/EBPf in granulopoiesis. Mol. Cell. Biol. 21, 3789-3806 (2001).
99. McLemore, M. L. et al. STAT.3 activation is required for normal G.CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204 (2001).
100. Feldman, G. M. et al. STAT5A.deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90, 1768-1776 (1997).
101. Mui, A. L., Wakao, H., Harada, N., OfFarrell, A. M. & Miyajima, A. Interleukin.3, granulocyte-macrophage colony-stimulating factor, and interleukin.5 transduce signals through two forms of STAT5. J. Leukoc. Biol. 57, 799-803 (1995).
102. Kimura, A. et al. The transcription factors STAT5A/B regulate GM.CSF-mediated granulopoiesis. Blood 114, 4721-4728 (2009).
103. Kimura, A. et al. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J. Biol. Chem. 279, 6905-6910 (2004).
104. Alexander, W. S. & Hilton, D. J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Ann. Rev. Immunol. 22, 503-529 (2004).
105. Hortner, M. et al. Suppressor of cytokine signaling.3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J. Immunol. 169, 1219-1227 (2002).
106. Hermans, M. H. et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G.CSF-induced expansion of myeloid progenitor cells. Blood 101, 2584-2590 (2003).
107. Boyle, K. et al. The SOCS box of suppressor of cytokine signaling.3 contributes to the control of G.CSF responsiveness in vivo. Blood 110, 1466-1474 (2007).
108. Kreisel, D. et al. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J. Clin. Invest. 121, 265-276 (2011).
109. Wulczyn, F. G., Naumann, M. & Scheidereit, C. Candidate proto-oncogene bcl.3 encodes a subunitspecific inhibitor of transcription factor NF.fÈB. Nature 358, 597-599 (1992).
110. Dechend, R. et al. The Bcl.3 oncoprotein acts as a bridging factor between NF.fÈB/Rel and nuclear co.regulators. Oncogene 18, 3316-3323 (1999).
111. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L. & Murray, P. J. Shaping gene expression in activated and resting primary macrophages by IL.10. J. Immunol. 169, 2253-2263 (2002).
112. Kuwata, H. et al. IL.10.inducible Bcl.3 negatively regulates LPS-induced TNF-f production in macrophages. Blood 102, 4123-4129 (2003).
113. Carmody, R. J., Ruan, Q., Palmer, S., Hilliard, B. & Chen, Y. H. Negative regulation of toll-like receptor signaling by NF.fÈB p50 ubiquitination blockade. Science 317, 675-678 (2007).
114. Ueda, Y., Cain, D. W., Kuraoka, M., Kondo, M. & Kelsoe, G. IL.1R type I.dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 182, 6477-6484 (2009).
115. van Wessem, K. J., Heeres, M., Leliefeld, P. H., Koenderman, L. & Leenen, L. P. Lipopolysaccharide and hemorrhagic shock cause systemic inflammation by different mechanisms. J. Trauma Acute Care Surg. 74, 37-43; discussion 43-34 (2013).
116. Ueda, Y., Kondo, M. & Kelsoe, G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201, 1771-1780 (2005).
117. Ueda, Y., Yang, K., Foster, S. J., Kondo, M. & Kelsoe, G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J. Exp. Med. 199, 47-58 (2004).
118. Ma, Q., Jones, D. & Springer, T. A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10, 463-471 (1999).
119. Martin, C. et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583-593 (2003).
120. Cain, D. W., Snowden, P. B., Sempowski, G. D. & Kelsoe, G. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS ONE 6, e19957 (2011).
121. Bugl, S. et al. Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood 121, 723-733 (2013).
122. Yang, C., Li, Y. C. & Kuter, D. J. The physiological response of thrombopoietin (c.Mpl ligand) to thrombocytopenia in the rat. Br. J. Haematol. 105, 478-485 (1999).
123. Stoffel, R., Wiestner, A. & Skoda, R. C. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87, 567-573 (1996).
124. Saito, Y., Boddupalli, C. S., Borsotti, C. & Manz, M. G. Dendritic cell homeostasis is maintained by nonhematopoietic and T.cell-produced Flt3.ligand in steady state and during immune responses. Eur. J. Immunol. 43, 1651-1658 (2013).
125. Bartocci, A. et al. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc. Natl Acad. Sci. USA 84, 6179-6183 (1987).
126. Kristinsson, S. Y. et al. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J. Clin. Oncol. 29, 2897-2903 (2011).
127. Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B.cell lymphoma. Nature Genet. 43, 830-837 (2011).
128. Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101-105 (2011).
129. Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119 (2011).
130. Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenstromfs macroglobulinemia. N. Engl. J. Med. 367, 826-833 (2012).